help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klein, K. O.
Right arrow Articles by Chang, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klein, K. O.
Right arrow Articles by Chang, R. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
Medline Plus Health Information
*Herbal Medicine
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 9 4077-4079
Copyright © 2003 by The Endocrine Society


Special Feature

Estrogen Bioactivity in Fo-Ti and Other Herbs Used for Their Estrogen-Like Effects as Determined by a Recombinant Cell Bioassay

Karen Oerter Klein, Mona Janfaza, Jeffrey A. Wong and R. Jeffrey Chang

University of California–San Diego, San Diego, California 92123

Address all correspondence and requests for reprints to: Karen Oerter Klein, M.D., Pediatric Endocrinologist, Children’s Hospital and Health Center, 3020 Children’s Way–MC 5103, San Diego, California 92123.

One of the most important issues in women’s health concerns the risks and benefits of estrogen replacement therapy. Continual uncertainty and lack of consensus regarding estrogen replacement therapy has driven many women to seek alternative sources of estrogen, including herbal remedies. We adapted a recombinant cell bioassay to measure estrogen bioactivity in herbs. We studied, in vitro, estrogen bioactivity in red clover, dong quai, black cohosh, soy, licorice, chaste tree berry, fo-ti, and hops. Soy, clover, licorice, and hops have a large amount of measurable estrogen bioactivity, as suspected, based on previous reports using other methods. We discovered surprisingly high estrogen activity in extracts of fo-ti not previously reported. Chaste tree berry, black cohosh, and dong quai did not have measurable activity with this method. We also discovered that removal of a glycone group from soy increases its estrogen bioactivity significantly. We conclude that this recombinant cell bioassay for estradiol can be used to measure bioactivity in herbal products. The preparations of fo-ti studied had estrogen activity of 409 ± 55 pmol/liter estradiol equivalents per microgram of herb, which is 1/300th the activity of 17ß-estradiol. Clinical studies are underway to determine the estrogen bioactivity in women using dietary supplements containing these herbs.

This work was supported in part by a gift from Natural Alternatives International.

Abbreviations: ER, Estrogen receptor; SoyA, soy aglycone.




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Cvoro, S. Paruthiyil, J. O. Jones, C. Tzagarakis-Foster, N. J. Clegg, D. Tatomer, R. T. Medina, M. Tagliaferri, F. Schaufele, T. S. Scanlan, et al.
Selective Activation of Estrogen Receptor-{beta} Transcriptional Pathways by an Herbal Extract
Endocrinology, February 1, 2007; 148(2): 538 - 547.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. M. Harris, E. Besselink, S. M. Henning, V. L. W. Go, and D. Heber
Phytoestrogens Induce Differential Estrogen Receptor Alpha- or Beta-Mediated Responses in Transfected Breast Cancer Cells
Experimental Biology and Medicine, September 1, 2005; 230(8): 558 - 568.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
S. E Fugate and C. O Church
Nonestrogen Treatment Modalities for Vasomotor Symptoms Associated with Menopause
Ann. Pharmacother., September 1, 2004; 38(9): 1482 - 1499.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Cho, W. Park, S. Lee, W. Ahn, and Y. Lee
Ginsenoside-Rb1 from Panax ginseng C.A. Meyer Activates Estrogen Receptor-{alpha} and -{beta}, Independent of Ligand Binding
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3510 - 3515.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society